Century-old shipwreck mystery unmasked by volunteer divers
Diving to depths of 160 metres off the coast of Wollongong in NSW, volunteer divers from the Sydney Project are the first people to lay eyes on the coal ship SS Nemesis since its disappearance in 1904.
The Nemesis vanished in a storm after leaving Newcastle for Melbourne with a full hold on July 8, sinking with all 32 crew on board.
The wreck's whereabouts were unknown for more than 100 years until a remote sensing company stumbled across the coal ship while trying to locate cargo containers lost off the Sydney coast.
The CSIRO has completed mapping of the wreck using remote-operated vehicles but the leader of the Sydney Project dive team says nothing compares to laying human eyes on a long-lost ship.
"We saw there is the cradle for the lifeboats, which was cool to see because you don't normally see these things intact on other shipwrecks," Samir Alhafith told AAP.
"Seeing things like a steam relief valve on the wreck, no one knew before this was actually a steam ship."
A century in the making, the four divers involved in the June 18 expeditions took nine minutes to reach the wreck and spent a further nine minutes surveying the wreckage.
Mr Alhafith says the Nemesis is a unique wreck because it has significant damage at both the front and rear of the ship but other parts of the hold are well-preserved.
The coal ship has since become a haven for thousands of fish including wobbegong sharks, although the human cost of the tragedy is not lost on the divers.
"You're looking at a lump of metal on the ground but there is a human connection to this particular object and in this case, there are relatives that lost their loved ones," Mr Alhafith said.
Heritage NSW assessments director Tim Smith was full of praise for the divers' "incredible feat" and said the information and images gathered will be invaluable for understanding the demise of the ship.
"These four divers have shone a light on the vessel's rich legacy, capturing never-seen-before footage of the ship up close," Mr Smith said in a statement.
One of Australia's most baffling maritime mysteries is in the spotlight after four divers captured incredible images of a century-old shipwreck.
Diving to depths of 160 metres off the coast of Wollongong in NSW, volunteer divers from the Sydney Project are the first people to lay eyes on the coal ship SS Nemesis since its disappearance in 1904.
The Nemesis vanished in a storm after leaving Newcastle for Melbourne with a full hold on July 8, sinking with all 32 crew on board.
The wreck's whereabouts were unknown for more than 100 years until a remote sensing company stumbled across the coal ship while trying to locate cargo containers lost off the Sydney coast.
The CSIRO has completed mapping of the wreck using remote-operated vehicles but the leader of the Sydney Project dive team says nothing compares to laying human eyes on a long-lost ship.
"We saw there is the cradle for the lifeboats, which was cool to see because you don't normally see these things intact on other shipwrecks," Samir Alhafith told AAP.
"Seeing things like a steam relief valve on the wreck, no one knew before this was actually a steam ship."
A century in the making, the four divers involved in the June 18 expeditions took nine minutes to reach the wreck and spent a further nine minutes surveying the wreckage.
Mr Alhafith says the Nemesis is a unique wreck because it has significant damage at both the front and rear of the ship but other parts of the hold are well-preserved.
The coal ship has since become a haven for thousands of fish including wobbegong sharks, although the human cost of the tragedy is not lost on the divers.
"You're looking at a lump of metal on the ground but there is a human connection to this particular object and in this case, there are relatives that lost their loved ones," Mr Alhafith said.
Heritage NSW assessments director Tim Smith was full of praise for the divers' "incredible feat" and said the information and images gathered will be invaluable for understanding the demise of the ship.
"These four divers have shone a light on the vessel's rich legacy, capturing never-seen-before footage of the ship up close," Mr Smith said in a statement.
One of Australia's most baffling maritime mysteries is in the spotlight after four divers captured incredible images of a century-old shipwreck.
Diving to depths of 160 metres off the coast of Wollongong in NSW, volunteer divers from the Sydney Project are the first people to lay eyes on the coal ship SS Nemesis since its disappearance in 1904.
The Nemesis vanished in a storm after leaving Newcastle for Melbourne with a full hold on July 8, sinking with all 32 crew on board.
The wreck's whereabouts were unknown for more than 100 years until a remote sensing company stumbled across the coal ship while trying to locate cargo containers lost off the Sydney coast.
The CSIRO has completed mapping of the wreck using remote-operated vehicles but the leader of the Sydney Project dive team says nothing compares to laying human eyes on a long-lost ship.
"We saw there is the cradle for the lifeboats, which was cool to see because you don't normally see these things intact on other shipwrecks," Samir Alhafith told AAP.
"Seeing things like a steam relief valve on the wreck, no one knew before this was actually a steam ship."
A century in the making, the four divers involved in the June 18 expeditions took nine minutes to reach the wreck and spent a further nine minutes surveying the wreckage.
Mr Alhafith says the Nemesis is a unique wreck because it has significant damage at both the front and rear of the ship but other parts of the hold are well-preserved.
The coal ship has since become a haven for thousands of fish including wobbegong sharks, although the human cost of the tragedy is not lost on the divers.
"You're looking at a lump of metal on the ground but there is a human connection to this particular object and in this case, there are relatives that lost their loved ones," Mr Alhafith said.
Heritage NSW assessments director Tim Smith was full of praise for the divers' "incredible feat" and said the information and images gathered will be invaluable for understanding the demise of the ship.
"These four divers have shone a light on the vessel's rich legacy, capturing never-seen-before footage of the ship up close," Mr Smith said in a statement.
One of Australia's most baffling maritime mysteries is in the spotlight after four divers captured incredible images of a century-old shipwreck.
Diving to depths of 160 metres off the coast of Wollongong in NSW, volunteer divers from the Sydney Project are the first people to lay eyes on the coal ship SS Nemesis since its disappearance in 1904.
The Nemesis vanished in a storm after leaving Newcastle for Melbourne with a full hold on July 8, sinking with all 32 crew on board.
The wreck's whereabouts were unknown for more than 100 years until a remote sensing company stumbled across the coal ship while trying to locate cargo containers lost off the Sydney coast.
The CSIRO has completed mapping of the wreck using remote-operated vehicles but the leader of the Sydney Project dive team says nothing compares to laying human eyes on a long-lost ship.
"We saw there is the cradle for the lifeboats, which was cool to see because you don't normally see these things intact on other shipwrecks," Samir Alhafith told AAP.
"Seeing things like a steam relief valve on the wreck, no one knew before this was actually a steam ship."
A century in the making, the four divers involved in the June 18 expeditions took nine minutes to reach the wreck and spent a further nine minutes surveying the wreckage.
Mr Alhafith says the Nemesis is a unique wreck because it has significant damage at both the front and rear of the ship but other parts of the hold are well-preserved.
The coal ship has since become a haven for thousands of fish including wobbegong sharks, although the human cost of the tragedy is not lost on the divers.
"You're looking at a lump of metal on the ground but there is a human connection to this particular object and in this case, there are relatives that lost their loved ones," Mr Alhafith said.
Heritage NSW assessments director Tim Smith was full of praise for the divers' "incredible feat" and said the information and images gathered will be invaluable for understanding the demise of the ship.
"These four divers have shone a light on the vessel's rich legacy, capturing never-seen-before footage of the ship up close," Mr Smith said in a statement.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Perth Now
6 hours ago
- Perth Now
Prize shines light on top Aussie women in STEM research
Women working in science, technology, engineering or mathematics sectors are being encouraged to apply for a world-first prize for emerging researchers. The inaugural Marie Krogh Young Women in Science prize, launched by healthcare company Novo Nordisk, will consist of a $50,000 cash prize as well as $5000 for seven finalists. It's named in honour of Danish physician Marie Krogh (1874-1943), who pioneered treatment for diabetes as one of the first women in Denmark to earn a doctorate in medicine. In Australia, women make up 37 per cent of university enrolments in STEM and hold just 15 per cent of jobs in those sectors. The prize aims to recognise mid-career women in STEM for their contributions to science and medicine and recognise future leaders, Murdoch Children's Research Institute director Kathryn North said. "Supporting the next generation of women in science and medicine isn't just about equity, it's about excellence," Professor North said. The judging panel is made up of several esteemed scientists and doctors, including Royal Children's Hospital centre for community child health director Sharon Goldfeld. It was exciting for an international company to recognise the contributions of Australian women in STEM, Professor Goldfeld told AAP. "Awards like this try to right some of the imbalance in the sector. It's not that there are no women in STEM, there are amazing women, but this is a leg up," she said. "We talk about the 'cliff' in research where often early career researchers are tracking along well but then can't quite make it to the next stage. A prize like this helps to fix that." Judges would be on the lookout for applicants who could communicate their research well, alongside excellent ideas. "I am blown away by the amazing women scientists of today and their ability to traverse all sorts of sciences and think cleverly about the way they communicate," Prof Goldfeld said. "We are looking for the STEM researcher who is not only excellent but also able to say why their research project is going to make a difference." Applications are now open, with finalists to be honoured at a Parliament House reception and awards dinner in Canberra in November 2025.
The Advertiser
a day ago
- The Advertiser
Mini hearts to save cancer survivors from heart disease
Breast cancer survivors at risk of severe heart disease due to chemotherapy and other treatments could benefit from a new drug to protect them from cardiovascular illness. In Australia, more than 21,000 people are diagnosed with breast cancer and about 3300 die from the disease each year. But the treatments helping patients survive chemotherapy and antibody-based therapies are also putting them at risk of heart failure, arrhythmias or other cardiovascular conditions years later. Heart disease related to cancer treatment is emerging as a significant threat to breast cancer survivors, with 30 per cent going on to develop potentially life-threatening heart complications. A team of scientists at the Heart Research Institute are using lab-grown "mini hearts" - the size of a grain of sand created from patient blood samples - to test drugs that could one day be given alongside chemotherapy. "We currently have limited knowledge on why cardiotoxicity occurs and which women will be most impacted," lead researcher Professor Julie McMullen said. "This research has the opportunity to identify women at risk of cardiotoxicity before symptoms are present, so we can develop drugs to protect the heart during and after cancer treatment." A protective drug would have been vital for Lee Hunt, who has experienced long-term heart damage from rounds of chemotherapy and Herceptin, a targeted therapy medication. "You never recover after cancer, but I was doing well until about five years after my treatment finished and I started experiencing dizzy spells," Ms Hunt told AAP. "It turned out the chemotherapy had affected my heart and I have permanent heart weakness. It won't kill me but it does need to be managed carefully. "Cancer treatment may save your life but that needs to be a good quality of life." The heart damage could sometimes be worse than the cancer itself, HRI research officer Dr Clara Liu Chung Ming said. "We want to give patients a therapy that can be safely delivered with their cancer treatment, to protect the heart before any damage occurs," she said. "It's about saving hearts as well as lives." While the research project is still in the pre-clinical stage, its potential is significant. The microscopic 3D "mini heart" models mimic aspects of how the human heart functions. "Our mini hearts replicate how a real heart contracts and responds to stress," Dr Liu Chung Ming said. "We expose them to chemotherapy and see how they react, then introduce our drug and see if it helps." The next step in the project will be to use breast cancer patient blood samples to generate personalised mini hearts. Breast cancer survivors at risk of severe heart disease due to chemotherapy and other treatments could benefit from a new drug to protect them from cardiovascular illness. In Australia, more than 21,000 people are diagnosed with breast cancer and about 3300 die from the disease each year. But the treatments helping patients survive chemotherapy and antibody-based therapies are also putting them at risk of heart failure, arrhythmias or other cardiovascular conditions years later. Heart disease related to cancer treatment is emerging as a significant threat to breast cancer survivors, with 30 per cent going on to develop potentially life-threatening heart complications. A team of scientists at the Heart Research Institute are using lab-grown "mini hearts" - the size of a grain of sand created from patient blood samples - to test drugs that could one day be given alongside chemotherapy. "We currently have limited knowledge on why cardiotoxicity occurs and which women will be most impacted," lead researcher Professor Julie McMullen said. "This research has the opportunity to identify women at risk of cardiotoxicity before symptoms are present, so we can develop drugs to protect the heart during and after cancer treatment." A protective drug would have been vital for Lee Hunt, who has experienced long-term heart damage from rounds of chemotherapy and Herceptin, a targeted therapy medication. "You never recover after cancer, but I was doing well until about five years after my treatment finished and I started experiencing dizzy spells," Ms Hunt told AAP. "It turned out the chemotherapy had affected my heart and I have permanent heart weakness. It won't kill me but it does need to be managed carefully. "Cancer treatment may save your life but that needs to be a good quality of life." The heart damage could sometimes be worse than the cancer itself, HRI research officer Dr Clara Liu Chung Ming said. "We want to give patients a therapy that can be safely delivered with their cancer treatment, to protect the heart before any damage occurs," she said. "It's about saving hearts as well as lives." While the research project is still in the pre-clinical stage, its potential is significant. The microscopic 3D "mini heart" models mimic aspects of how the human heart functions. "Our mini hearts replicate how a real heart contracts and responds to stress," Dr Liu Chung Ming said. "We expose them to chemotherapy and see how they react, then introduce our drug and see if it helps." The next step in the project will be to use breast cancer patient blood samples to generate personalised mini hearts. Breast cancer survivors at risk of severe heart disease due to chemotherapy and other treatments could benefit from a new drug to protect them from cardiovascular illness. In Australia, more than 21,000 people are diagnosed with breast cancer and about 3300 die from the disease each year. But the treatments helping patients survive chemotherapy and antibody-based therapies are also putting them at risk of heart failure, arrhythmias or other cardiovascular conditions years later. Heart disease related to cancer treatment is emerging as a significant threat to breast cancer survivors, with 30 per cent going on to develop potentially life-threatening heart complications. A team of scientists at the Heart Research Institute are using lab-grown "mini hearts" - the size of a grain of sand created from patient blood samples - to test drugs that could one day be given alongside chemotherapy. "We currently have limited knowledge on why cardiotoxicity occurs and which women will be most impacted," lead researcher Professor Julie McMullen said. "This research has the opportunity to identify women at risk of cardiotoxicity before symptoms are present, so we can develop drugs to protect the heart during and after cancer treatment." A protective drug would have been vital for Lee Hunt, who has experienced long-term heart damage from rounds of chemotherapy and Herceptin, a targeted therapy medication. "You never recover after cancer, but I was doing well until about five years after my treatment finished and I started experiencing dizzy spells," Ms Hunt told AAP. "It turned out the chemotherapy had affected my heart and I have permanent heart weakness. It won't kill me but it does need to be managed carefully. "Cancer treatment may save your life but that needs to be a good quality of life." The heart damage could sometimes be worse than the cancer itself, HRI research officer Dr Clara Liu Chung Ming said. "We want to give patients a therapy that can be safely delivered with their cancer treatment, to protect the heart before any damage occurs," she said. "It's about saving hearts as well as lives." While the research project is still in the pre-clinical stage, its potential is significant. The microscopic 3D "mini heart" models mimic aspects of how the human heart functions. "Our mini hearts replicate how a real heart contracts and responds to stress," Dr Liu Chung Ming said. "We expose them to chemotherapy and see how they react, then introduce our drug and see if it helps." The next step in the project will be to use breast cancer patient blood samples to generate personalised mini hearts. Breast cancer survivors at risk of severe heart disease due to chemotherapy and other treatments could benefit from a new drug to protect them from cardiovascular illness. In Australia, more than 21,000 people are diagnosed with breast cancer and about 3300 die from the disease each year. But the treatments helping patients survive chemotherapy and antibody-based therapies are also putting them at risk of heart failure, arrhythmias or other cardiovascular conditions years later. Heart disease related to cancer treatment is emerging as a significant threat to breast cancer survivors, with 30 per cent going on to develop potentially life-threatening heart complications. A team of scientists at the Heart Research Institute are using lab-grown "mini hearts" - the size of a grain of sand created from patient blood samples - to test drugs that could one day be given alongside chemotherapy. "We currently have limited knowledge on why cardiotoxicity occurs and which women will be most impacted," lead researcher Professor Julie McMullen said. "This research has the opportunity to identify women at risk of cardiotoxicity before symptoms are present, so we can develop drugs to protect the heart during and after cancer treatment." A protective drug would have been vital for Lee Hunt, who has experienced long-term heart damage from rounds of chemotherapy and Herceptin, a targeted therapy medication. "You never recover after cancer, but I was doing well until about five years after my treatment finished and I started experiencing dizzy spells," Ms Hunt told AAP. "It turned out the chemotherapy had affected my heart and I have permanent heart weakness. It won't kill me but it does need to be managed carefully. "Cancer treatment may save your life but that needs to be a good quality of life." The heart damage could sometimes be worse than the cancer itself, HRI research officer Dr Clara Liu Chung Ming said. "We want to give patients a therapy that can be safely delivered with their cancer treatment, to protect the heart before any damage occurs," she said. "It's about saving hearts as well as lives." While the research project is still in the pre-clinical stage, its potential is significant. The microscopic 3D "mini heart" models mimic aspects of how the human heart functions. "Our mini hearts replicate how a real heart contracts and responds to stress," Dr Liu Chung Ming said. "We expose them to chemotherapy and see how they react, then introduce our drug and see if it helps." The next step in the project will be to use breast cancer patient blood samples to generate personalised mini hearts.
West Australian
a day ago
- West Australian
Mini hearts to save cancer survivors from heart disease
Breast cancer survivors at risk of severe heart disease due to chemotherapy and other treatments could benefit from a new drug to protect them from cardiovascular illness. In Australia, more than 21,000 people are diagnosed with breast cancer and about 3300 die from the disease each year. But the treatments helping patients survive chemotherapy and antibody-based therapies are also putting them at risk of heart failure, arrhythmias or other cardiovascular conditions years later. Heart disease related to cancer treatment is emerging as a significant threat to breast cancer survivors, with 30 per cent going on to develop potentially life-threatening heart complications. A team of scientists at the Heart Research Institute are using lab-grown "mini hearts" - the size of a grain of sand created from patient blood samples - to test drugs that could one day be given alongside chemotherapy. "We currently have limited knowledge on why cardiotoxicity occurs and which women will be most impacted," lead researcher Professor Julie McMullen said. "This research has the opportunity to identify women at risk of cardiotoxicity before symptoms are present, so we can develop drugs to protect the heart during and after cancer treatment." A protective drug would have been vital for Lee Hunt, who has experienced long-term heart damage from rounds of chemotherapy and Herceptin, a targeted therapy medication. "You never recover after cancer, but I was doing well until about five years after my treatment finished and I started experiencing dizzy spells," Ms Hunt told AAP. "It turned out the chemotherapy had affected my heart and I have permanent heart weakness. It won't kill me but it does need to be managed carefully. "Cancer treatment may save your life but that needs to be a good quality of life." The heart damage could sometimes be worse than the cancer itself, HRI research officer Dr Clara Liu Chung Ming said. "We want to give patients a therapy that can be safely delivered with their cancer treatment, to protect the heart before any damage occurs," she said. "It's about saving hearts as well as lives." While the research project is still in the pre-clinical stage, its potential is significant. The microscopic 3D "mini heart" models mimic aspects of how the human heart functions. "Our mini hearts replicate how a real heart contracts and responds to stress," Dr Liu Chung Ming said. "We expose them to chemotherapy and see how they react, then introduce our drug and see if it helps." The next step in the project will be to use breast cancer patient blood samples to generate personalised mini hearts.
